Tokio Marine Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,045
Closed -$334K 380
2017
Q2
$334K Sell
10,045
-3,934
-28% -$122K 0.05% 277
2017
Q1
$449K Sell
13,979
-3,859
-22% -$132K 0.06% 255
2016
Q4
$647K Sell
17,838
-6,813
-28% -$272K 0.07% 179
2016
Q3
$1.13M Sell
24,651
-2,745
-10% -$143K 0.12% 138
2016
Q2
$1.38M Hold
27,396
0.14% 134
2016
Q1
$1.47M Buy
27,396
+2,061
+8% +$121K 0.15% 137
2015
Q4
$1.66M Hold
25,335
0.18% 114
2015
Q3
$1.43M Sell
25,335
-976
-4% -$63.3K 0.15% 134
2015
Q2
$1.55M Sell
26,311
-4,865
-16% -$300K 0.15% 133
2015
Q1
$1.94M Sell
31,176
-4,909
-14% -$285K 0.18% 115
2014
Q4
$2.08M Sell
36,085
-13,519
-27% -$753K 0.18% 123
2014
Q3
$2.67M Sell
49,604
-1,755
-3% -$93K 0.19% 126
2014
Q2
$2.69M Hold
51,359
0.18% 119
2014
Q1
$2.71M Sell
51,359
-5,600
-10% -$259K 0.18% 125
2013
Q4
$2.28M Hold
56,959
0.14% 149
2013
Q3
$2.15M Sell
56,959
-6,982
-11% -$272K 0.14% 156
2013
Q2
$2.51M Buy
+63,941
New +$2.49M 0.16% 139

Other funds holding TEVA

Tokio Marine Asset Management's TEVA Position: Q3 2017 in Review

Tokio Marine Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 10,045 shares — an estimated $334K sold.

Tokio Marine Asset Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.71M in Q1 2014. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Tokio Marine Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Tokio Marine Asset Management sold 10,045 Teva Pharmaceuticals shares in Q3 2017, an estimated $334K.
  • Tokio Marine Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Tokio Marine Asset Management's Teva Pharmaceuticals position peaked at $2.71M in Q1 2014.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Tokio Marine Asset Management's 13F filing for Q3 2017, filed 30 Oct 2017.